For individuals
Blood test and app
Blog
FAQ
Buy
Sign in
For business
Nightingale for business
Health initiatives
For investors
Investor pages
Nightingale as an investment
Financial information
Share and shareholders
Governance
Investor relations
AGM 2021
Releases
IPO
Suomeksi
For research
Blood Biomarker Analysis
Biomarkers
Publications
About us
Company
Technology
News
Careers
Contact
For individuals
For business
For investors
About us
Method description
April 24, 2012
Quantitative high-throughput metabolomics: a new era in epidemiology and genetics
Read full study
For individuals
Blood test and app
Blog
FAQ
Buy
Sign in
For business
Nightingale for business
Health initiatives
For investors
Investor pages
Nightingale as an investment
Financial information
Share and shareholders
Governance
Investor relations
AGM 2021
Releases
IPO
Suomeksi
For research
Blood Biomarker Analysis
Biomarkers
Publications
About us
Company
Technology
News
Careers
Contact
Get our newsletter
Interested in getting the latest news about Nightingale? Subscribe to our newsletter.
→
Nightingale Health Oyj
Mannerheimintie 164a, 00300 Helsinki, Finland
Contact →
© 2020 Nightingale Health
Terms and policies